Cargando…
Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade
BACKGROUND: Stimulation of the immune system by targeting the PD-1/PD-L1 pathway can result in activation of anti-tumor immunity. Besides its clinical benefit immune checkpoint therapy leads to significant immune-related adverse events (irAEs). Some rare irAEs are not well described yet but are crit...
Autores principales: | Läubli, Heinz, Hench, Jürgen, Stanczak, Michal, Heijnen, Ingmar, Papachristofilou, Alexandros, Frank, Stephan, Zippelius, Alfred, Stenner-Liewen, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477093/ https://www.ncbi.nlm.nih.gov/pubmed/28642817 http://dx.doi.org/10.1186/s40425-017-0249-y |
Ejemplares similares
-
Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events
por: Läubli, Heinz, et al.
Publicado: (2018) -
Larotrectinib Response in NTRK3 Fusion-Driven Diffuse High-Grade Glioma
por: König, David, et al.
Publicado: (2022) -
Pembrolizumab-induced optic neuropathy – a case report
por: Daetwyler, Eveline, et al.
Publicado: (2023) -
Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma
por: Läubli, Heinz, et al.
Publicado: (2015) -
Tumor-associated carbohydrates and immunomodulatory lectins as targets for cancer immunotherapy
por: Rodrigues Mantuano, Natalia, et al.
Publicado: (2020)